262 related articles for article (PubMed ID: 16353059)
1. [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol].
Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA
Kardiologiia; 2005; 45(11):17-23. PubMed ID: 16353059
[No Abstract] [Full Text] [Related]
2. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
3. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Wright JT; Bakris GL; Bell DS; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Holdbrook FK; Lukas MA; Iyengar M
J Clin Hypertens (Greenwich); 2007 Nov; 9(11):842-9. PubMed ID: 17978591
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.
Kohno T; Yoshikawa T; Yoshizawa A; Nakamura I; Anzai T; Satoh T; Ogawa S
Cardiovasc Drugs Ther; 2005 Oct; 19(5):347-55. PubMed ID: 16382297
[TBL] [Abstract][Full Text] [Related]
5. Beta-blockers in 2007?
Straughan JL
Cardiovasc J Afr; 2007; 18(2):90-2. PubMed ID: 17497045
[No Abstract] [Full Text] [Related]
6. COMET: a proposed mechanism of action to explain the results and concerns about dose.
Hjalmarson A; Waagstein F
Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544
[No Abstract] [Full Text] [Related]
7. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
[TBL] [Abstract][Full Text] [Related]
8. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
9. A clinical pharmacologist's response to Dr Milton Packer's perspective on the results of the COMET trial.
Shepherd AM
J Card Fail; 2003 Dec; 9(6):454-7. PubMed ID: 14966784
[No Abstract] [Full Text] [Related]
10. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
Arslan S; Erol MK; Bozkurt E; Acikel M; Gundogdu F; Atesal S; Senocak H
Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429
[TBL] [Abstract][Full Text] [Related]
11. The effect of beta-blocker use on cyclosporine level in cardiac transplant recipients.
Bader FM; Hagan ME; Crompton JA; Gilbert EM
J Heart Lung Transplant; 2005 Dec; 24(12):2144-7. PubMed ID: 16364863
[TBL] [Abstract][Full Text] [Related]
12. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
Morgan T; Snowden R; Butcher L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
[TBL] [Abstract][Full Text] [Related]
13. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
[TBL] [Abstract][Full Text] [Related]
14. Beta blockers in heart failure.
Dargie HJ
Lancet; 2003 Jul; 362(9377):2-3. PubMed ID: 12853188
[No Abstract] [Full Text] [Related]
15. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
Jawa A; Nachimuthu S; Pendergrass M; Asnani S; Fonseca V
J Diabetes Complications; 2008; 22(5):303-8. PubMed ID: 18413195
[TBL] [Abstract][Full Text] [Related]
16. Body weight changes with beta-blocker use: results from GEMINI.
Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL;
Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935
[TBL] [Abstract][Full Text] [Related]
17. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
[TBL] [Abstract][Full Text] [Related]
18. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
Ozbilen S; Eren MA; Turan MN; Sabuncu T
Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol outclasses the other beta-blockers.
Cardiovasc J S Afr; 2001; 12(2):120-1. PubMed ID: 11474696
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
Talbert RL
Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
